W3C home > Mailing lists > Public > public-credentials@w3.org > April 2020

Re: Important Issue for Immunity Credentials

From: D.W.Chadwick <info@verifiablecredentials.info>
Date: Wed, 8 Apr 2020 16:32:01 +1200
To: Alex Puig <alex@caelumlabs.com>, Adrian Gropper <agropper@healthurl.com>
Cc: Moses Ma <moses.ma@futurelabconsulting.com>, Christopher Allen <ChristopherA@lifewithalacrity.com>, Credentials Community Group <public-credentials@w3.org>
Message-ID: <626e97ac-0417-9023-974b-8b03f20883e4@verifiablecredentials.info>
Hi Alex

do you want a VC example in JSON, or a signed example using JWT? These 
are the only ones I have. If you want a ZKP or JSON-LD signed one you 
will need to ask someone else.

Note that the example we are using is not a medically correct one, but 
rather is a template that will need to be completed with medical details 
once these have been standardised. Perhaps Adrian might be able to fill 
in more details?

kind regards

David

On 08/04/2020 15:58, Alex Puig wrote:
> This is relevant to me.
>
> We are working on an implementation of 
> https://github.com/DP-3T/documents using Zenroom.
>
> An immunity credential example would help us.
>
> Alex
>
> El mar., 7 abr. 2020 a las 23:27, Adrian Gropper 
> (<agropper@healthurl.com <mailto:agropper@healthurl.com>>) escribió:
>
>     HT to Juan C.
>     https://unherd.com/2020/04/how-far-away-are-immunity-passports/
>
>     I would ask: IWhat is the role of VC relative to local or
>     decentralized governance to solving this issue?
>
>     - Adrian
>
>
>     On Tue, Apr 7, 2020 at 3:10 PM D.W.Chadwick
>     <info@verifiablecredentials.info
>     <mailto:info@verifiablecredentials.info>> wrote:
>
>         Hi Moses
>
>         over the last week or so we have developed a proof of concept
>         COVID-19
>         Immunity Certificate application demonstrator built on our
>         application
>         independent verifiable credential middleware. We would like to
>         participate in challenge (1) headed by Victoriano. I am
>         currently in the
>         process of making a video of our demo
>
>         Kind regards
>
>         David
>
>         On 08/04/2020 06:51, Moses Ma wrote:
>         > Hi Christopher et al,
>         >
>         > You're absolutely right. This is why we have recruited: Dr. Ab
>         > Osterhaus to join our team - he is one of the world's
>         leading experts
>         > in coronaviruses, and his team was first to sequence the
>         SARS virus,
>         > Dr. Tony Cox - a data scientist who specializes in
>         epidemiology, and
>         > Triall.io - a clinical research organization that has run
>         over 30
>         > Phase I-IV trials and is the developer of the first
>         blockchain tool
>         > for clinical trials. All of our proposed pilots will adhere to
>         > clinical research methodologies that preserve patient
>         privacy and
>         > insure validated data production.
>         >
>         > However, what we could use more of are privacy experts who
>         can quickly
>         > produce innovative working solutions.
>         >
>         > Two challenges we've identified are: (1) the use of verifiable
>         > credentials to serve as digital certificates of immunity,
>         and (2) the
>         > possibility of developing interoperable contact managers and
>         globally
>         > unique IDs to enable international travel. A big thanks to
>         Victoriano
>         > Giralt for stepping up to manage the first one, but I think
>         we still
>         > need to find a MacGyvered approach to solving the second...
>         in a way
>         > that has a low barrier to federation and adoption. To be
>         brutally
>         > honest, we are triaging a solution, and we need to see
>         reality clearly
>         > as to whether DIDs can add value short term.
>         >
>         > If you'd like to work on these sub-projects, please let me
>         know.
>         > Again, this is an action-primary team that will need to deliver
>         > software on an super-agile basis.
>         >
>         > Anyway, I promised to share the recording of our first call
>         so you
>         > know what we're up to, and you can find it here:
>         >
>         https://www.dropbox.com/s/rqhpum88k28usti/Zoom-DefenderDIDcall-040620.mp4?dl=0
>         >
>         > Finally, I'll try to make time for CCG calls, but I'm getting
>         > exponentially busier these days.
>         >
>         >
>         > Stay healthy everyone!
>         >
>         > Moses
>         >
>         >
>         > PS, thisis a very interesting article about user acceptance
>         of contact
>         > managers:https://045.medsci.ox.ac.uk/user-acceptance -
>         respondents
>         > were most concerned about “government using the app as an
>         excuse to
>         > increase surveillance after the epidemic”.
>         >
>         >
>         > <https://045.medsci.ox.ac.uk/user-acceptance>
>         >
>         > On 4/7/20 10:19 AM, Christopher Allen wrote:
>         >> As was discussed briefly in the call today, if we are going
>         to talk
>         >> about #Covid19 technology solutions, we must partner with
>         health &
>         >> epidemiological experts to do it right.
>         >>
>         >> For instance, it has been proposed that we support some
>         kind of
>         >> digital immunity certificate. Even if we ignore its possible
>         >> human-rights & privacy risks, it can have still have risky
>         public
>         >> health care choices:
>         >>
>         >> https://unherd.com/2020/04/how-far-away-are-immunity-passports/
>         >>
>         >> “If you issue immunity passports on this basis, /barely a
>         third /of
>         >> the people you give them to will actually be immune.
>         “There’s nothing
>         >> peculiar about this statistically,” Kevin McConway, an
>         emeritus
>         >> professor of statistics at the Open University, told me.
>         “It’s just
>         >> Bayes’ theorem
>         <https://en.wikipedia.org/wiki/Bayes%27_theorem>.” The
>         >> likelihood of you having had Covid-19, if you’ve had a
>         positive test,
>         >> depends not just on the accuracy of the test but on the
>         prevalence in
>         >> the population you’re looking at.
>         >> …
>         >> In the end, that’s going to be a horribly cold-blooded
>         calculation.
>         >> If you let people out when they’re 90% likely to be immune,
>         that
>         >> means one person in 10 is going to be at risk of getting and
>         >> spreading the disease. Is that risk a price worth paying
>         for reducing
>         >> the real costs (economic, social, physical, mental) of
>         isolation? I
>         >> don’t know and I’m glad I don’t have to work it out. But
>         someone has
>         >> to. And they’ll have to start by getting a reasonably
>         effective test,
>         >> and testing hundreds of thousands of people, to see how
>         many of us
>         >> have had it.”
>         >>
>         >> — Christopher Allen
>         >
>         >
>         > --
>         >
>         > *Moses Ma | Managing Partner*
>         >
>         > moses.ma@futurelabconsulting.com
>         <mailto:moses.ma@futurelabconsulting.com> | moses@ngenven.com
>         <mailto:moses@ngenven.com>
>         >
>         > v+1.415.568.1068 | skype mosesma | /linktr.ee/moses.tao/
>         <http://linktr.ee/moses.tao/>
>         > <http://linktr.ee/moses.tao>
>         >
>         > FutureLab provides strategy, ideation and technology for
>         breakthrough
>         > innovation and third generation blockchains.
>         >
>         > Learn more at /www.futurelabconsulting.com/
>         <http://www.futurelabconsulting.com/>
>         > <http://futurelabconsulting.com>. For calendar invites,
>         please cc:
>         > mosesma@gmail.com <mailto:mosesma@gmail.com>
>         >
>         >
>         > Or whet your appetite by reading /Agile Innovation/
>         >
>         <http://www.amazon.com/Agile-Innovation-Revolutionary-Accelerate-Engagement/dp/B00SSRSZ9A>
>
>         > | /Quantum Design Sprint/
>         >
>         <https://www.amazon.com/Quantum-Design-Sprint-Application-Disruptive/dp/1799143864>
>
>         > | my blog at /psychologytoday.com/
>         <http://psychologytoday.com/>
>         > <http://www.psychologytoday.com/blog/the-tao-innovation>.
>         >
>         > NOTICE TO RECIPIENT: THIS E-MAIL IS MEANT FOR ONLY THE INTENDED
>         > RECIPIENT OF THE TRANSMISSION. IF YOU RECEIVED THIS E-MAIL
>         IN ERROR,
>         > ANY REVIEW, USE, DISSEMINATION, DISTRIBUTION, OR COPYING OF
>         THIS
>         > E-MAIL IS STRICTLY PROHIBITED. PLEASE NOTIFY THE SENDER
>         IMMEDIATELY OF
>         > THE ERROR BY RETURN E-MAIL AND PLEASE DELETE THIS MESSAGE
>         FROM YOUR
>         > SYSTEM. THIS EMAIL SHOULD NOT BE CONSIDERED BINDING; HARD COPY
>         > DOCUMENTS ARE REQUIRED TO CREATE LEGALLY BINDING
>         COMMITMENTS. FOR
>         > CALENDAR INVITES, PLEASE CC: MOSESMA@GMAIL.COM
>         <mailto:MOSESMA@GMAIL.COM>
>         >
>
>
>
> -- 
>
> Alex Puig
>
> CTO
>
> +34 678544357
>
> alex@caelumlabs.com <mailto:alex@caelumlabs.com>
>
> Follow us!Twitter <https://twitter.com/caelumlabs>|
>
> linkedin <https://www.linkedin.com/company/caelumlabs/>| Newsletter 
> <http://newsletter.caelumlabs.com/>|Gitlab <https://gitlab.com/caelumlabs>
>
> IMPORTANT: The contents of this email and any attachments are 
> confidential. It is strictly forbidden to share any part of this 
> message with any third party, without a written consent of the sender. 
> If you received this message by mistake, please reply to this message 
> and follow with its deletion, so that we can ensure such a mistake 
> does not occur in the future.
>
> *
>
> *
Received on Wednesday, 8 April 2020 04:32:25 UTC

This archive was generated by hypermail 2.4.0 : Thursday, 24 March 2022 20:24:58 UTC